Fujifilm doubles down on Boston foothold, renting some major legroom to chase cell and gene therapies
Fujifilm has finally crossed the t’s and dotted the i’s on a new public-private partnership for a center focused on genetically modified cell therapies after the idea first came to fruition in late 2019.
On Thursday, the Japanese conglomerate and the Massachusetts Center for Advanced Biological Innovation and Manufacturing announced that they’d secured $76 million in funding and signed a lease for a 40,000 square-foot site in the greater Boston area.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.